Merck KGaA (LON:0O14)
112.09
+1.14 (1.03%)
At close: Aug 15, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | 200.00K | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Life Science | - | Log In | Log In | Log In | Log In | Upgrade |
Life Science Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Oncology | 2.01B | Log In | Log In | Log In | Log In | Upgrade |
Oncology Growth | 3.98% | Log In | Log In | Log In | Log In | Upgrade |
Neurology & Immunology | 1.69B | Log In | Log In | Log In | Log In | Upgrade |
Neurology & Immunology Growth | 0.49% | Log In | Log In | Log In | Log In | Upgrade |
Fertility | 1.53B | Log In | Log In | Log In | Log In | Upgrade |
Fertility Growth | -4.33% | Log In | Log In | Log In | Log In | Upgrade |
Display Solutions | 748.30M | Log In | Log In | Log In | Log In | Upgrade |
Display Solutions Growth | -0.28% | Log In | Log In | Log In | Log In | Upgrade |
Surface Solutions | 406.50M | Log In | Log In | Log In | Log In | Upgrade |
Surface Solutions Growth | -5.83% | Log In | Log In | Log In | Log In | Upgrade |
Semiconductor Solutions | 2.63B | Log In | Log In | Log In | Log In | Upgrade |
Semiconductor Solutions Growth | 0.60% | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular, Metabolism and Endocrinology | 2.95B | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular, Metabolism and Endocrinology Growth | 4.61% | Log In | Log In | Log In | Log In | Upgrade |
Other Healthcare | 280.50M | Log In | Log In | Log In | Log In | Upgrade |
Other Healthcare Growth | 19.95% | Log In | Log In | Log In | Log In | Upgrade |
Process Solutions | 3.52B | Log In | Log In | Log In | Log In | Upgrade |
Process Solutions Growth | 7.02% | Log In | Log In | Log In | Log In | Upgrade |
Life Science Services | 721.80M | Log In | Log In | Log In | Log In | Upgrade |
Life Science Services Growth | -10.79% | Log In | Log In | Log In | Log In | Upgrade |
Science & Lab Solutions | 4.67B | Log In | Log In | Log In | Log In | Upgrade |
Science & Lab Solutions Growth | -0.03% | Log In | Log In | Log In | Log In | Upgrade |
Other | 200.00K | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Life Science EBITDA | 2.59B | Log In | Log In | Log In | Log In | Upgrade |
Life Science EBITDA Growth | 4.80% | Log In | Log In | Log In | Log In | Upgrade |
Healthcare EBITDA | 2.99B | Log In | Log In | Log In | Log In | Upgrade |
Healthcare EBITDA Growth | 17.47% | Log In | Log In | Log In | Log In | Upgrade |
Electronics EBITDA | 969.60M | Log In | Log In | Log In | Log In | Upgrade |
Electronics EBITDA Growth | -5.54% | Log In | Log In | Log In | Log In | Upgrade |
Corporate/Others EBITDA | -481.80M | Log In | Log In | Log In | Log In | Upgrade |
Corporate/Others EBITDA Growth | 37.08% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Europe | 6.17B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 5.01% | Log In | Log In | Log In | Log In | Upgrade |
North America | 5.71B | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | -2.84% | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific | 7.02B | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific Growth | 2.08% | Log In | Log In | Log In | Log In | Upgrade |
Latin America | 1.48B | Log In | Log In | Log In | Log In | Upgrade |
Latin America Growth | 3.00% | Log In | Log In | Log In | Log In | Upgrade |
Middle East & Africa | 781.20M | Log In | Log In | Log In | Log In | Upgrade |
Middle East & Africa Growth | 3.29% | Log In | Log In | Log In | Log In | Upgrade |